Raymond James boosted the price target for DexCom, Inc. (NASDAQ: DXCM) from $127 to $138. Raymond James analyst Jayson Bedford upgraded the stock from Outperform to Strong Buy. DexCom shares rose 1.8% to $117.75 in pre-market trading.
Analysts at UBS are bearish on several U.S. retail stocks. A predicted consumer spending slowdown will trickle down to the industry’s earnings for the remainder of the year, they said.
Jay Sole downgraded five U.S. retail stocks and lowered 2023 calendar year estimates by 10%. The five stocks downgraded from a Neutral rating to Sell: